Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

A Hard Look: How Did China Pharma Growth Fall So Fast, So Steeply?

This article was originally published in PharmAsia News

Executive Summary

While many are still shocked by the double-digit drop in quarterly pharma sales in the world’s second-largest economy, the underlying factors for the fast deterioration in China have in fact been brewing for some time and are multi-faceted, Yang Dongsheng of the R&D based Pharmaceutical Association Committee (RDPAC) tells PharmAsia News in an exclusive interview.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register